<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-viruses-12-00518">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Smith</surname>
    <given-names>G.E.</given-names>
   </name>
   <name>
    <surname>Flyer</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Raghunandan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kpamegan</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Courbron</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Fries</surname>
    <given-names>L.F.</given-names>
    <suffix>3rd</suffix>
   </name>
   <name>
    <surname>Glenn</surname>
    <given-names>G.M.</given-names>
   </name>
  </person-group>
  <article-title>Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus</article-title>
  <source>Vaccine</source>
  <year>2013</year>
  <volume>31</volume>
  <fpage>4305</fpage>
  <lpage>4313</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.07.043</pub-id>
  <pub-id pub-id-type="pmid">23891795</pub-id>
 </element-citation>
</ref>
